Pharmaceutical Grade Nootropics Nsi189 Phosphate Denmark Bulk Stock for Cognitive Impairment CAS: 1270138-41-4

Description:

NSI-189 is a benzylpiperizine-aminiopyridine, a novel chemical entity that stimulates neurogenesis of human hippocampus-derived neural stem cells in vitro and stimulates neurogenesis in murine hippocampus in vivo. Emerging evidence also indicates that NSI-189 phosphate has regionally specific effects insofar as neurogenesis is observed largely in the subventricular zone of the hippocampus. Results from a preliminary proof of concept study suggests that NSI-189 may be capable of mitigating depressive symptoms and improve cognitive function in adults with DSM-5-defined Major Depressive Disorder (MDD).

NSI-189 is a new investigational antidepressant, which is purported to work differently from existing antidepressants. Researchers suggest this drug may potentially help those who do not respond to conventional medications. Research is also ongoing for its cognitive-enhancing effects. However, NSI-189 failed in a recent clinical trial. Learn about all the research behind this drug.

• Cognitive impairment and radiation-induced cognitive impairments
• Diabetic neuropathy, a form of nerve damage caused by diabetes
• Ischemic stroke
• Angelman Syndrome (a genetic disorder that causes developmental disabilities and nerve-related symptoms)

• Every product we sell is 100% Authentic & Top Quality.
• Your Satisfaction is 100% Guaranteed or your money back.

• USA Domestic Delivery.
• Express and Expedite Shipping Available